CDIO Cardio Diagnostics Holdings, Inc.: Operating Profitability

Symbol and logo of brand Cardio Diagnostics Holdings, Inc. (CDIO)

Cardio Diagnostics (CDIO) is in a stage of technological growth, scaling AI services for blood analysis independently of macroeconomic cycles. Genetic tests are generating steady B2B demand, establishing a foundation for future free cash flow. However, current revenue is limited by the pace of system implementation in clinics. The operating margin trajectory demonstrates business efficiency, and this metric settled at -42649.80.

CDIO - Cardio Diagnostics Holdings Inc. Operating Profit Rate over the range 04/28/2023 - 11/19/2026

CDIO (Cardio Diagnostics Holdings Inc.): analytical breakdowns and indicator data

- share price and consensus valuation forecast:
Basic company analysis:Cardio Diagnostics Holdings, CDIO
Finished products of Cardio Diagnostics Holdings

Operating margin measures the share of profit from core operations before interest and taxes, demonstrating cost management efficiency and the fundamental resilience of the business. Analyzing this operating profitability metric allows investors to understand how successfully Cardio Diagnostics (CDIO) monetizes its genetic tests and epigenetic research for the prevention of cardiological risks amid the diversification of medical revenues.

Competitors of Cardio Diagnostics (CDIO)

Operating Sales Margin A|DGX: Operating Profit Rate|Operating Margin ILMN|EXAS (exactsciences.com) - Operating Profit Rate|Revvity Corp - Operating Sales Margin|Operating Profit Rate BIO|Anbio Corp - Operating Margin|Operating Return on Sales Sterigenics|QDEL (QuidelOrtho Corp) - Operating Sales Margin|OPK: Operating Profit Ratio|CDNA (CareDx) - Operating Margin|Maravai LifeSciences Holdings, Inc. (MRVI) - Profitability of Operations|Operating Profitability Fulgent Genetics, Inc. (FLGT)|LAB - Operating Return on Sales|Operating Margin CTKB (cytekbio.com)|Operating Profit Rate OSUR|XGN - Operating Profitability|MDxHealth (MDXH) - Operating Sales Margin|LUCD (Lucid Diagnostics) - Operating Sales Margin|Prenetics Global Ltd (PRE) - Operating Margin|Operating Profitability Insight Molecular Diagnostics|TRIB: Operating Profit Rate|Operating Profitability ProPhase (PRPH)|AIMD - Operating Return on Sales|Operating Profitability Co-Diagnostics, Inc. CODX|Operating Margin Heart Test Laboratories HSCS|Biomerica Inc - Operating Margin|Operating Return on Sales onconetix.gcs-web.com|Virax Biolabs Group (VRAX) - Operating Profitability|BJDX - Profitability of Operations|AWH (Aspira Women's Health, Inc.) - Operating Margin|Accelerate Diagnostics, Inc (AXDX) - Profitability of Operations|Operating Margin CNTG|ENZ - Operating Return on Sales|Operating Profit Rate Fresh2 Group Ltd|Genetic Technologies (GENE) - Operating Return on Sales|ME - Operating Profitability|Profitability of Operations Psychemedics Corp PMD